Citigroup
MYOV

Citigroup’s Myovant Sciences Ltd. MYOV Stock Holding History

Citigroup’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-122,752
Closed -$3.31M – 6030
2022
Q4 		$3.31M Sell
122,752
-26,767
-18% -$704K ﹤0.01% 1713
2022
Q3 		$2.69M Buy
149,519
+41,388
+38% +$661K ﹤0.01% 1935
2022
Q2 		$1.34M Buy
108,131
+61,884
+134% +$683K ﹤0.01% 2399
2022
Q1 		$616K Sell
46,247
-143,022
-76% -$1.92M ﹤0.01% 3364
2021
Q4 		$2.95M Buy
189,269
+87,812
+87% +$1.68M ﹤0.01% 2290
2021
Q3 		$2.28M Sell
101,457
-75,034
-43% -$1.65M ﹤0.01% 2437
2021
Q2 		$4.02M Buy
176,491
+174,871
+10,795% +$3.68M ﹤0.01% 2099
2021
Q1 		$33K Buy
1,620
+587
+57% +$13.4K ﹤0.01% 4956
2020
Q4 		$29K Sell
1,033
-2
-0.2% -$39 ﹤0.01% 6427
2020
Q3 		$15K Sell
1,035
-5,909
-85% -$110K ﹤0.01% 6390
2020
Q2 		$143K Buy
6,944
+6,817
+5,368% +$92.7K ﹤0.01% 5284
2020
Q1 		$1K Sell
127
-8
-6% -$90 ﹤0.01% 7541
2019
Q4 		$2K Buy
+135
New +$1.36K ﹤0.01% 7570
2019
Q1 		– Sell
-66
Closed -$1K – 7877
2018
Q4 		$1K Buy
66
+51
+340% +$1K ﹤0.01% 7619
2018
Q3 		$0 Buy
+15
New +$339 ﹤0.01% 7913
2018
Q1 		– Sell
-41
Closed -$1K – 7723
2017
Q4 		$1K Hold
41
– – ﹤0.01% 7509
2017
Q3 		$1K Sell
41
-6
-13% -$73 ﹤0.01% 7177
2017
Q2 		$1K Sell
47
-64
-58% -$793 ﹤0.01% 7243
2017
Q1 		$1K Sell
111
-10,590
-99% -$121K ﹤0.01% 7128
2016
Q4 		$133K Buy
+10,701
New +$124K ﹤0.01% 5596

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's MYOV Position: Q1 2023 in Review

Citigroup sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 122,752 shares — an estimated $3.31M sold.

Citigroup first reported a position in MYOV in Q4 2016 and held it in 20 quarters. The position peaked at $4.02M in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Citigroup reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 122,752 Myovant Sciences Ltd. shares in Q1 2023, an estimated $3.31M.
  • Citigroup first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 20 quarters.
  • Citigroup's Myovant Sciences Ltd. position peaked at $4.02M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.